# OnCo record michael-heinrich (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/michael-heinrich/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "michael-heinrich" ;
  schema:name "Michael C. Heinrich"@en ;
  schema:description "Oregon physician-scientist who showed that the KIT mutation type in a GIST predicts how well imatinib works, discovered PDGFRA mutations in the tumours without KIT mutations, and led NAVIGATOR, which established avapritinib for PDGFRA D842V disease."@en ;
  schema:url <https://onco.cc/people/michael-heinrich/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "gist", "targeted-therapy", "trialist" ;
  schema:jobTitle "Medical oncologist and laboratory scientist, Oregon Health & Science University and Portland VA" ;
  schema:sameAs <https://orcid.org/0000-0003-3790-0478> ;
  onco:cancers <https://onco.cc/cancers/gist-pdgfra-d842v/>, <https://onco.cc/cancers/gist-kit-exon-11/>, <https://onco.cc/cancers/gist/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:institutions <https://onco.cc/institutions/ohsu-knight/> ;
  onco:trials <https://onco.cc/trials/navigator/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-heinrich-kit-mutation-imatinib-response-jco-2003/>, <https://onco.cc/key-papers/paper-navigator-avapritinib-heinrich-lancet-oncol-2020/>, <https://onco.cc/key-papers/paper-heinrich-pdgfra-gist-science-2003/> ;
  schema:affiliation <https://onco.cc/institutions/ohsu-knight/> .